These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3070107)

  • 1. [Bactericidal activity of the complement and its synergistic effects with cephem antibiotics against Serratia marcescens].
    Kiyota H; Onodera S; Kishimoto K; Goto H; Machida T; Yokota T
    Nihon Hinyokika Gakkai Zasshi; 1988 May; 79(5):910-7. PubMed ID: 3070107
    [No Abstract]   [Full Text] [Related]  

  • 2. The synergic effects of quinolones and oral cephem antibiotics on Serratia marcescens.
    Otsuki M; Nishino T
    J Antimicrob Chemother; 1996 Nov; 38(5):771-6. PubMed ID: 8961046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical studies on urinary tract infections caused by Serratia marcescens. I. Clinical and bacteriological studies on urinary tract infections caused by Serratia marcescens].
    Sakai S; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):467-84. PubMed ID: 6353020
    [No Abstract]   [Full Text] [Related]  

  • 4. [Urinary tract infections due to Serratia marcescens. I. Antimicrobial susceptibility patterns of clinical isolates of Serratia marcescens (author's transl)].
    Igari J; Kosakai N
    Jpn J Antibiot; 1977 Oct; 30(10):840-6. PubMed ID: 338940
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical aspects of urinary tract infection by Serratia marcescens].
    Miyakita H; Kawashima T; Kinoshita H; Kawamura N
    Hinyokika Kiyo; 1984 Feb; 30(2):153-8. PubMed ID: 6377857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serovar and antibiotic-sensitivity of Serratia marcescens isolated from urinary tract infections].
    Okuda T; Hirosawa Y; Enda N; Zenyoji H
    Kansenshogaku Zasshi; 1984 Jun; 58(6):483-90. PubMed ID: 6436403
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative evaluation of the speed of bactericidal activity of cephalosporin and other antibiotics on Serratia marcescens strains isolated from an epidemic focus].
    Michelone G; Perversi L; Verani DA; Marone P; Concia E
    G Ital Chemioter; 1982; 29(2):103-7. PubMed ID: 6764625
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of combination of cefsulodin and beta-lactam antibiotics against Serratia marcescens.
    Kondo M; Tsuchiya K
    J Antibiot (Tokyo); 1981 Oct; 34(10):1327-33. PubMed ID: 7031032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Timed bacteriostatic and bactericidal activities of latamoxef against clinical strains of gram-negative bacteria].
    Masuda G; Negishi M; Young C; Mukaiyama T; Hanai N; Uchikawa S; Thoma T; Yamazaki E
    Jpn J Antibiot; 1983 Jan; 36(1):16-21. PubMed ID: 6221128
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial susceptibility of Acinetobacter calcoaceticus, Serratia marcescens, Pseudomonas fluorescens and Pseudomonas maltophilia to three novel cephalosporin-like antibiotics.
    Tofte RW; Crossley K
    J Antimicrob Chemother; 1980 Nov; 6(6):799-801. PubMed ID: 6777362
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta-lactamine associations. In vitro synergism and clinical results].
    Acar JF
    Pathol Biol (Paris); 1971; 19(11):593-7. PubMed ID: 4997292
    [No Abstract]   [Full Text] [Related]  

  • 12. Methods to determine antipathogenic potential of phenolic and flavonoid compounds against urinary pathogen Serratia marcescens.
    Annapoorani A; Parameswari R; Pandian SK; Ravi AV
    J Microbiol Methods; 2012 Oct; 91(1):208-11. PubMed ID: 22759832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro synergistic effects of fisetin and norfloxacin against aquatic isolates of Serratia marcescens.
    Dong J; Ruan J; Xu N; Yang Y; Ai X
    FEMS Microbiol Lett; 2016 Jan; 363(1):fnv220. PubMed ID: 26567906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
    Yayan J; Ghebremedhin B; Rasche K
    BMC Pharmacol Toxicol; 2016 Mar; 17():10. PubMed ID: 27004519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies on ceftibuten in the urinary field infection].
    Suzuki K; Nagata Y; Horiba M
    Jpn J Antibiot; 1990 Nov; 43(11):2003-10. PubMed ID: 2287061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient factors contributing to the emergence of gentamicin-resistant Serratia marcescens.
    Yu VL; Oakes CA; Axnick KJ; Merigan TC
    Am J Med; 1979 Mar; 66(3):468-72. PubMed ID: 373434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug resistance of bacteria--the current status and future prospect. 4. Serratia].
    Kimura S
    Nihon Rinsho; 1984 Mar; 42(3):671-5. PubMed ID: 6381804
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combined effects of micronomicin and latamoxefi in vitro synergistic activities].
    Kurimoto T; Okachi R
    Jpn J Antibiot; 1983 Jul; 36(7):1599-603. PubMed ID: 6418932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
    Saito M; Azuma K; Nishino T; Tanino T
    Jpn J Antibiot; 1983 Oct; 36(10):2833-43. PubMed ID: 6325746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
    Kawakami Y; Okimura Y; Horiuchi N; Kanai M
    Jpn J Antibiot; 1982 Sep; 35(9):2314-7. PubMed ID: 6292543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.